Genentech, A Member of the Roche Group Patient Advocacy Relations In Patient Advocacy Relations, Meg leads Genentech's engagements with lung, kidney, prostate and bladder cancer patient advocacy groups and contributes to critical business needs including partnerships in biomarker testing as well as Genentech's novel MyInfoMyWay launch that will support lung cancer patient navigation. (more ...) Meg joins PAR from Hematology where she was a Sr. TLL. In this role, she managed complex relationships with thought leaders, cross-functional teams, external vendors and collaboration partners to inform strategy and advance patient care. She is a passionate representative on the D&I Coalition and leads Hematology’s D&I Advisory Council . She spent the first 20 years of her career championing patient-centered initiatives at various organizations including Director of Patient Services at The Leukemia & Lymphoma Society and Executive Director for Cook for Your Life. Meg holds a BA from Hamilton College and an MA in Counseling Psychology and Counselor Education from the University of Colorado. HEC member category Industry
